/
Log inGet free API keyAccount
Menu
InvestorsCompaniesFit CheckerDocsPricingGet free API key

Companies / Syndex Bio

Syndex Bio

Cambridge, United Kingdom

Syndex Bio develops and applies a novel platform technology called mcPCR for amplifying DNA methylation

Healthcare & Biotech

Syndex Bio, based in Cambridge, United Kingdom, has 2 investors on file, among them ARCH Venture Partners and OMX Ventures. Its latest round on record is Seed, 24 Feb 2026. Its site was last checked 13 Nov 2026: site answers.

syndex.bio

Funding

1 round on record
Latest roundSeed24 Feb 2026
Since that round9 monthsno later round on record
Investors in its rounds11 with a VCinfo profile
Feb 2026SeedLed by ARCH Venture Partners

Round sizes and total raised are on Fundup AI, our sister product for funding data.

Investors

2 investors on file
InvestorEvidenceType
ARCH Venture PartnersPortfolio pageVenture capital
OMX VenturesPortfolio pageVenture capital

More from ARCH Venture Partners

113 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (91%), AI & Machine Learning (3%), Industrial & Manufacturing (2%).

Agios PharmaceuticalsAgios develops therapies for people with rare diseases, with a focus o…AledadeAledade provides actionable insights and expert support for clinicians…Alnylam PharmaceuticalsAlnylam Pharmaceuticals develops RNAi therapeutics.Altos LabsAltos Labs is focused on understanding how to translate the science of…ArsenalbioArsenal Biosciences, Inc. is a cell therapy company that discovers and…

See ARCH Venture Partners' full profile · Who invests alongside it

More from OMX Ventures

27 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (96%), Fintech (4%).

Compass PathwaysCompass Pathways develops new clinical standards for mental health car…Constructive BioConstructive Bio designs and manufactures new-to-nature proteins for n…Delix TherapeuticsDelix Therapeutics is developing novel therapeutics to address brain h…Finch TherapeuticsFinch Therapeutics has a portfolio of innovative microbiome assets wit…Ginkgo BioworksGinkgo Bioworks provides autonomous labs for biotechnology, allowing s…

See OMX Ventures' full profile · Who invests alongside it

A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data

Free account · no card

Get Syndex Bio and its investors as data

Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when ARCH Venture Partners adds a company.

Work email, sign-in link by email. Already have an account? Log in
Your API keyRead the docs
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/companies/syndex.bio/investors

# also
GET /v1/companies/syndex.bio
GET /v1/companies/syndex.bio/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing